HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A S Multani Selected Research
A S Multani Research Topics
Disease
6
Neoplasms (Cancer)
12/2016 - 07/2000
2
Melanoma (Melanoma, Malignant)
10/2001 - 12/2000
2
Neoplasm Metastasis (Metastasis)
10/2001 - 07/2000
1
Polyploidy
12/2016
1
Ovarian Neoplasms (Ovarian Cancer)
12/2016
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2016
1
Endometrial Neoplasms (Endometrial Cancer)
04/2013
1
Carcinoma in Situ
04/2013
1
Drug-Related Side Effects and Adverse Reactions
12/2012
1
Fever (Fevers)
12/2012
1
Typhoid Fever (Typhoid)
12/2012
1
Coma (Comas)
10/2007
1
Acidosis
10/2007
1
Poisoning
10/2007
1
Vision Disorders (Hemeralopia)
10/2007
1
Colonic Neoplasms (Colon Cancer)
09/2001
1
Spontaneous Remission
12/2000
1
Nevus (Nevi)
12/2000
1
Mouth Neoplasms (Oral Cancer)
07/2000
1
Lymphoma (Lymphomas)
07/2000
Drug/Important Bio-Agent (IBA)
2
Telomerase (Telomerase Reverse Transcriptase)
IBA
04/2013 - 12/2000
2
Purinergic P1 Receptors (Adenosine Receptor)
IBA
10/2001 - 07/2000
2
Cytostatic Agents
IBA
10/2001 - 07/2000
2
Adenosine (Adenocard)
FDA Link
Generic
10/2001 - 07/2000
1
Tubulin
IBA
12/2016
1
Red Fluorescent Protein
IBA
12/2016
1
Green Fluorescent Proteins
IBA
12/2016
1
Indicators and Reagents (Reagents)
IBA
12/2016
1
Proto-Oncogene Proteins c-mdm2
IBA
01/2016
1
Proteins (Proteins, Gene)
FDA Link
01/2016
1
ethyl monochloroacetate (EMCA)
IBA
04/2013
1
Quinolones
IBA
12/2012
1
Ofloxacin (Ofloxacine)
FDA Link
Generic
12/2012
1
Azithromycin (Zithromax)
FDA Link
Generic
12/2012
1
Methanol (Carbinol)
IBA
10/2007
1
DNA (Deoxyribonucleic Acid)
IBA
12/2001
1
N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosine
IBA
10/2001
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2001
1
Methylnitronitrosoguanidine (MNNG)
IBA
09/2001
1
DNA Probes
IBA
12/2000
1
Thapsigargin
IBA
07/2000
1
Staurosporine
IBA
07/2000
1
Chromatin
IBA
07/2000
1
Pharmaceutical Preparations
IBA
07/2000
1
Anvirzel
IBA
07/2000
1
oleandrin
IBA
07/2000
Therapy/Procedure
1
Therapeutics
10/2001
1
Oral Administration
10/2001